CClinicalTrials.gg
CompletedNCT04607291Updated Aug 12, 2021Results posted

Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening

A Phase 1 interventional study of Community Health Service and Survey Administration in Colorectal Carcinoma, sponsored by Roswell Park Cancer Institute. Completed at 1 site in United States. Open to participants aged 50 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-12.

Sponsored by Roswell Park Cancer Institute · Phase 1, Interventional, and Health services research

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Sep 2019, registered Sep 2020).
Phase
Phase 1
Study type
Interventional
Enrollment
183
Allocation
Not applicable
Ages
50 Years to 75 Years
Sex
All
01

Study summary

This phase I study investigates how well a health service program called Witness CARES Services works in increasing access and adherence to colorectal cancer screening in patients who have not undergone a colorectal screening in the past year. Providing patients with navigational and screening services via Witness CARES Services may improve access to and adherence levels of colorectal screening.

Read the detailed description

PRIMARY OBJECTIVES:

I. Test the feasibility of Witness CARES (WC) Services to achieve colorectal carcinoma (CRC) screening for non-adherent Medicaid clients.

II. Develop an algorithm for predicting CRC screening outcomes following intervention services.

OUTLINE:

Patients who are not prepared for a colonoscopy or stool test receive educational materials, messages, and videos electronically or by mail with information about colorectal screening and are followed up by phone within 2 weeks. Patients desiring colonoscopy receive navigator assistance with obtaining the screening (e.g.,determining gastrointestinal doctor, scheduling appointment, prep materials and process, transportation, escort). Patients desiring a stool test receive navigator assistance by facilitating fecal tests.

After completion of study, patients are followed up periodically.

02

Conditions studied

  • Colorectal Carcinoma
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's enrollment of 183 is above the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Roswell Park Cancer Institute is the lead sponsor of 412 studies on the registry; 62 are open to participants now.

Of its 38 completed or terminated interventional studies of FDA-regulated products, 21 (55%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants who are non-adherent to CRC screening over the past year (i.e., no stool testing in past 11 months or colonoscopy for over 9 years)
  • Medicaid or Medicaid/Medicare subscribers
  • Uninsured patients may be included from Mercy Comprehensive Care Center (MCCC), but will only be eligible for services to obtain fecal immunochemical tests (FIT) through the New York State (NYS) Cancer Services Program

Exclusion criteria

Exclusion Criteria:

  • Any participants from the lists of gaps in care clients from insurance or primary care practices who report having had a colonoscopy in the past 9 years (or having positive findings such as polyps, 5 years) or having completed some type of fecal test for CRC will be excluded
  • Participants under 50 will be excluded unless they have been deemed high risk by their physician, and have a prescription for CRC screening
  • Participants symptomatic for CRC will be excluded from the study
05

Study design

Phase
Phase 1
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
183 participants (actual)

Study arms

  • Experimental
    Health services research (Witness CARES services) Intervention

    Patients who are not prepared for a colonoscopy or stool test receive educational materials, messages, and videos electronically or by mail with information about colorectal screening and are followed up by phone within 2 weeks. Patients desiring colonoscopy, receive navigators assistance with obtaining the screening (e.g.,determining gastrointestinal doctor, scheduling appointment, prep materials and process, transportation, escort). Patients desiring a stool test, receive navigators assistance by facilitating fecal tests.

    Other: Community Health Service · Other: Survey Administration

Interventions

  • OtherCommunity Health Service

    Receive Witness CARES services

  • OtherSurvey Administration

    Ancillary studies

06

What researchers measure

Primary outcomes

  1. Change in Screening Metrics

    After CRC screening, satisfaction surveys will be conducted in order to assess the services of the Witness Cares Program. Below are responses to basic follow-up questions.

    Time frame: Up to 12 months

  2. Model Development for Prediction of Intent and Colorectal Cancer (CRC) Screening Behaviors

    A telephone assessment of 118 self reported questions will be conducted in order to assess what factors are associated with CRC screening. The outcome of interest is CRC screening (colonoscopy or fecal immunochemical testing (FIT) test), which is treated as a binary outcome. The potential predictors include basic demographic characteristics as well as the survey sub-scales (based on the 118 self-reported questions).

    Time frame: Up to 12 months

Secondary outcomes

  1. Prediction of Which CRC Screening Test is Most Acceptable

    Data collected from surveys from the intent to screen clients will be used to help predict CRC screening test most acceptable

    Time frame: Up to 12 months

07

Results

Posted Aug 5, 2021

Participant flow

Participant flow — Overall Study
MilestoneHealth Services Research (Witness CARES Services) Intervention
Started183
Completed183
Not completed0

Outcome measures

PrimaryChange in Screening Metrics

After CRC screening, satisfaction surveys will be conducted in order to assess the services of the Witness Cares Program. Below are responses to basic follow-up questions.

Time frame:
Up to 12 months
Reported as:
Count of participants · Participants
Change in Screening Metrics
ParticipantsHealth Services Research (Witness CARES Services) Intervention
Definitely helped me complete my CRC screening — Yes42
Definitely helped me complete my CRC screening — No8
Needed Education or Help with At Home Test — Yes37
Needed Education or Help with At Home Test — No13
Needed Reminder Calls — Yes33
Needed Reminder Calls — No17
Needed Help understanding CRC Screening Tests — Yes31
Needed Help understanding CRC Screening Tests — No19
Likely to Refer a Friend to Witness Cares Services — Yes45
Likely to Refer a Friend to Witness Cares Services — No5
PrimaryModel Development for Prediction of Intent and Colorectal Cancer (CRC) Screening Behaviors

A telephone assessment of 118 self reported questions will be conducted in order to assess what factors are associated with CRC screening. The outcome of interest is CRC screening (colonoscopy or fecal immunochemical testing (FIT) test), which is treated as a binary outcome. The potential predictors include basic demographic characteristics as well as the survey sub-scales (based on the 118 self-reported questions).

Time frame:
Up to 12 months
Reported as:
Count of participants · Participants
Model Development for Prediction of Intent and Colorectal Cancer (CRC) Screening Behaviors
ParticipantsHealth Services Research (Witness CARES Services) Intervention
Screened56
Not Screened127
Statistical analysis
  • Health Services Research (Witness CARES Services) Intervention ·
SecondaryPrediction of Which CRC Screening Test is Most Acceptable

Data collected from surveys from the intent to screen clients will be used to help predict CRC screening test most acceptable

Time frame:
Up to 12 months
Reported as:
Count of participants · Participants
Prediction of Which CRC Screening Test is Most Acceptable
ParticipantsHealth Services Research (Witness CARES Services) Intervention
High Intent to Get Fit Test112
Low Intent to get Fit Test71
Unknown2
Statistical analysis
  • Health Services Research (Witness CARES Services) Intervention ·

Adverse events

Collected over 30 days post contact with navigator.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Health Services Research (Witness CARES Services) Intervention0/183 (0%)0/183 (0%)0/183 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Health Services Research (Witness CARES Services) Intervention
Mean60.0 ± 5.1
Sex: Female, Male
Sex: Female, Male(Participants)Health Services Research (Witness CARES Services) Intervention
Female118
Male65
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Health Services Research (Witness CARES Services) Intervention
American Indian or Alaska Native0
Asian3
Native Hawaiian or Other Pacific Islander0
Black or African American71
White87
More than one race0
Unknown or Not Reported22
Region of Enrollment
Region of Enrollment(participants)Health Services Research (Witness CARES Services) Intervention
United States183
Insurance Status
Insurance Status(Participants)Health Services Research (Witness CARES Services) Intervention
Medicare/Medicaid183
non Medicare/Medicaid0
Uninsured0
Screening Eligibility
Screening Eligibility(Participants)Health Services Research (Witness CARES Services) Intervention
Eligible183
non-Eligible0
08

Study locations

1 site
  • Roswell Park Cancer Institute
    Buffalo, New York 14263, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Mar 25, 2019

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 12, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04607291
Lead sponsor
Roswell Park Cancer Institute
Collaborators
National Cancer Institute (NCI)
Responsible party
Sponsor
First posted
Oct 29, 2020
Start date
Sep 1, 2019
Primary completion
May 14, 2020
Completion
May 14, 2021
Results posted
Aug 5, 2021
Last update
Aug 12, 2021

Study contacts

Deborah Erwin
principal investigator · Roswell Park Cancer Institute

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion